argenx
Sean Mc Cafferty, PhD, is a scientist specializing in discovery at argenx since December 2023. Prior to this role, Mc Cafferty served as a Senior Scientist at Ziphius Vaccines from March 2020 to August 2023 and completed a PhD at the Laboratory for Gene Therapy at Ghent University from October 2014 to March 2020. Mc Cafferty also holds a Master of Science in Biochemistry and Biotechnology and a Bachelor of Science in Biochemistry and Biotechnology, both obtained from Ghent University, where academic studies continued from 2007 to 2013.
This person is not in any teams
This person is not in any offices
argenx
32 followers
Argenx discovers, designs and develops innovative antibody therapeutics for its own pipeline of treatments for cancer and autoimmune diseases and for its partners. Harnessing our technology and know-how, we aim to meet the needs of patients by engineer...